| 1. |
慢性阻塞性肺疾病急性加重诊治专家组.慢性阻塞性肺疾病急性加重诊治中国专家共识(2014年修订版).国际呼吸杂志, 2014, 34:1-11.
|
| 2. |
Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax, 2008, 63:487-492.
|
| 3. |
陈绞, 楚世峰, 陈乃宏.糖皮质激素与抑郁发病相关机制研究发展.中国药理学通报, 2013, 29:1493-1495.
|
| 4. |
Hayashi Y, Senjyu H, Iguchi A, et al. Prevalence of depressive symptoms in Japanese male patients with chronic obstructive pulmonary disease. Psychiatry Clin Neurosci, 2011, 65:82-88.
|
| 5. |
Tetikkurt C, Ozdemir I, Tetikkurt S, et al. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Resp Med, 2011, 6:226-231.
|
| 6. |
Negi H, Sarkar M, Raval AD, et al. Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res, 2014, 139:402-408.
|
| 7. |
Yellowless PM, Alpers JH, Bodew JJ, et al. Psychiatric morbidity in patients with chronic airflow obstruction, Med J Aust 1987, 146:305-307.
|
| 8. |
卢冠男, 周宁, 邓园, 等.老年慢性阻塞性肺疾病患者抑郁相关因素调查分析.国际呼吸杂志, 2010, 30:13-15.
|
| 9. |
Al-shair K, Kolsum U, Dockry R, et al. Biomakers of systemic inflammation and depression and fatigue in modertate clinically stable COPD. Respir Res, 2011, 12:3.
|
| 10. |
Luqer TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav, 2014, 39:1418-1429.
|
| 11. |
Anacker C, Zunszain PA, Carvalho LA, et al. The glucocorticoid receptor:pivot of depression and of antidepressant treatment? Psychoneuroendocrinology, 2011, 36:415-425.
|
| 12. |
Kishnan V, Nestler EJ. The molecular neurobiology of depression. Nature, 2008, 455:894-902.
|
| 13. |
钟南山, 蔡闯.慢性阻塞性肺疾病与焦虑抑郁的关系.继续医学教育, 2007, 21:17-19.
|
| 14. |
李佳倩, 章璐, 陈芳, 等.慢性阻塞性肺疾病患者生活质量评估研究近况.现代医药卫生, 2012, 28:2481-2482.
|
| 15. |
Lou PA, Zhu Y, Chen PP, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China:a cross-sectional case control study. BMC Pulmon Med, 2012, 12:53.
|
| 16. |
Ottenheim NR, Giltay EJ, Zitman FG, et al. Risk of depressive symptoms in the oldest old subjects with chronic obstructive pulmonary disease:the Leiden 85-plus study. Am J Geriatr Psychiatry, 2010, 18:388-394.
|
| 17. |
王玉锋, 侯公林.抑郁症近代药物治疗.第四军医大学学报, 2006, 27:1526-1528.
|
| 18. |
Chuluunkhuu G, Nakahara N, Yanagisawa S, et al. The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous and dichotomous outcomes. Kobe J Med Sci, 2008, 54:E147-158.
|
| 19. |
陈元成, 胥卫川.万拉法辛与氟西汀治疗抑郁焦虑症状的临床对照研究.中国现代应用药学杂志, 2008, 25:737-738.
|
| 20. |
梁颖华, 王冬梅, 杨得坡, 等.贯叶金丝桃素及其衍生物的合成与神经药理学研究进展.中草药, 2007, 38:789-791.
|
| 21. |
Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD--a review. Respir Med, 2011, 105:1422-1433.
|
| 22. |
张少丽, 石少波.抑郁症治疗的研究进展.精神医学杂志, 2008, 21:156-160.
|
| 23. |
Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes, 2007, 5:17.
|
1/5
WeChat